U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Omadacycline

Last Revision: September 21, 2020.

Estimated reading time: 1 minute

CASRN: 389139-89-3

image 135263120 in the ncbi pubchem database

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the use of omadacycline during breastfeeding. It is unknown how much omadacycline is excreted into breastmilk, but the drug is only about 35% absorbed orally under optimal circumstances, and is probably less from milk because of its calcium content. The manufacturer states that breastfeeding is not recommended during treatment and for 4 days after the last dose. If an infant is breastfed, monitor the infant for possible effects on the gastrointestinal flora, such as diarrhea, candidiasis (e.g., thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis. As a theoretical precaution, avoid prolonged or repeat courses during nursing.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Omadacycline

CAS Registry Number

389139-89-3

Drug Class

Breast Feeding

Lactation

Anti-Infective Agents

Antibacterial Agents

Tetracyclines

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK535602PMID: 30601611

Views

Related information

Similar articles in PubMed

  • Review Eravacycline.[Drugs and Lactation Database (...]
    Review Eravacycline.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Minocycline.[Drugs and Lactation Database (...]
    Review Minocycline.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Tigecycline.[Drugs and Lactation Database (...]
    Review Tigecycline.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Tetracycline.[Drugs and Lactation Database (...]
    Review Tetracycline.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Sarecycline.[Drugs and Lactation Database (...]
    Review Sarecycline.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...